Robotic surgery breakthrough aims to slash lung cancer recovery time

NCT ID NCT05832112

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new robotic surgery technique for stage I lung cancer. Instead of making cuts between the ribs, surgeons place the robot's tools below the ribcage. The goal is to see if this approach is safe and feasible, and if it can reduce pain and hospital stays. The trial will enroll 20 patients at a single hospital in Canada.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
robotic surgery procedure (OTC RATS lobectomy)
What this could lead to
If successful, this technique could offer a less painful, faster-recovering surgical option for early-stage lung cancer patients.
What could go wrong
This is a very early, small pilot study (20 patients) testing feasibility and safety. The new approach may not work as hoped or could have unexpected complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER STAGE I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHUM

    Montreal, Quebec, H2X 0A9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.